Hahnemann’s demise should not be a surprise to any politicians in Philly

When the for-profit Tenet chain put Hahnemann up for sale two years ago, nobody else offered to buy it. It had lost money for more than a decade.

Hahnemann’s demise should not be a surprise to any politicians in Philly

When the for-profit Tenet chain put Hahnemann up for sale two years ago, nobody else offered to buy it. It had lost money for more than a decade.

Column

Accused sex trafficker Jeffrey Epstein’s old boss says he knows where the mystery millions came from

From his prison cell at Fort Dix, convicted fraudster Steven Hoffenberg began a campaign to expose his former assistant, Presidential friend and accused sex trafficker Jeffrey Epstein, of keeping stolen millions. Epstein's lawyers deny it all.
Column

Accused sex trafficker Jeffrey Epstein’s old boss says he knows where the mystery millions came from

From his prison cell at Fort Dix, convicted fraudster Steven Hoffenberg began a campaign to expose his former assistant, Presidential friend and accused sex trafficker Jeffrey Epstein, of keeping stolen millions. Epstein's lawyers deny it all.

Trump requested, Lockheed Martin delivered: Chesco helicopter plant to stay open

Lockheed Martin's Sikorsky helicopter plant in Coatesville, which makes the Marine One helicopters that fly President Trump around, will stay open an extra year, saving 465 jobs for the time being

Trump requested, Lockheed Martin delivered: Chesco helicopter plant to stay open

Lockheed Martin's Sikorsky helicopter plant in Coatesville, which makes the Marine One helicopters that fly President Trump around, will stay open an extra year, saving 465 jobs for the time being
More Stories

Philly area’s biggest bank writes down millions in bad loans to refinery, health-care facility

Shares of WSFS Financial Corp. dropped more than 4 percent in morning trading, slipping below $40 for the first time in a month.

Column

Incyte, buoyed by former DuPonters, has rising revenues and a busy drug pipeline, but the payoff will take years, CEO says

Incyte spent $1.2 billion last year on research, more than half of its $1.9 billion in sales, a serious commitment for a drug firm.

Labor, state, and city officials seek last-ditch rescue funds for Hahnemann University Hospital

But people familiar with the hospital’s operations said privately that they see little chance of a last-ditch rescue due to Hahnemann’s antiquated or ineffective admissions, billing and other basic systems.

Blood pact: Roche-Spark deal deadline pushed back as regulators check impact on prices, availability

Roche had hoped to buy Philly-based Spark for $4.3 billion this Spring, but regulators' worries about what combining the companies' hemophilia programs might do has delayed approval, possibly into next year,and depressed the share price

Fast-growing home medical supplier AdaptHealth to raise cash, go public

Fast growing Plymouth Meeting medical distributor AdaptHealth, with sales of over half a billion dollars a year in oxygen machines and sleep-apnea equipment, will go public after raising millions in private-equity deal

Column

Union leaders asked rebooted DuPont to change more than its slogan

DuPont has a long history of ill-fated purchases and sales from which its leaders never suffered. Now a DuPont union leader calls for the company to resume giving the workers stock options so they can share in the company's success.

Column

Joe Biden’s politics can be explained by Delaware’s shadowy past

Delaware is a lot more like the U.S. than early-voting Iowa or New Hampshire. Biden’s rise says a lot about how Democrats can win and lose.

WSFS Bank to lay off dozens at Beneficial’s Center City headquarters

The move is part of the Wilmington bank’s efforts to streamline operations at Beneficial, which it bought for $1.5 billion earlier this year.

Philly-based Century Therapeutics raises $250M to fight cancer with adult stem cells

Century uses self-renewing adult stem cells to create hat it hopes will be a faster and more efficient approach to treating cancer.

Philly-based construction supplier Unified Door raises Wall St. cash to to go national

Unified Door & Hardware, a 500-worker, South Jersey-based firm which has bought a string of East Coast commercial door firms, has attracted new capital from a New York private-equity firm and its backers

One of the Philly region’s top investors steps up to run University City Science Center board

The center’s properties now include 16 buildings spreading west from Drexel and north from Penn, branded as “uCity Square.”

FMC moves N.J. research staff to expanded R&D center in Delaware

FMC Corp. is moving its Princeton-area R&D staff to a former DuPont experimental farm in Delaware, where it will spend $50 million bulking up its global research headquarters

Column

Business tech firm in Blue Bell sold, plans hiring and growth

Anexinet, a survivor among the scrappy companies that connect Philly-area employers to fast-changing business software, has been sold to a New York private-equity fund that promises to grow the business outside its local markets

SPECIAL REPORTS
Investigative reports, featured series, and guides to living in the Philadelphia region, brought to you by The Inquirer.
WHAT ARE YOU CURIOUS ABOUT?
Send us your burning questions, or vote on other readers' questions that pique your interest. Our journalists will work to answer them.